Alterations in the turnover rate of dopamine D1 but not D2 receptors in the adult rat neostriatum after a neonatal dopamine denervation

Neurochemistry International

Volumn 30, Issue 6, 1997, Pages 613-621

  Dewar, Karen M ^a,b   Paquet, Maryse ^a   Reader, Tomás A ^b  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BRAIN RECEPTOR; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HOMOVANILLIC ACID; OXIDOPAMINE; RACLOPRIDE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENERVATION; DISSOCIATION CONSTANT; DOPAMINERGIC NERVE CELL; FEMALE; ISOTOPE LABELING; NEOSTRIATUM; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR UPREGULATION;

ANIMALIA; TRITIUM;

EID: 0030894915     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00069-1     Document Type: Article

References (56)

1. 2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat. Mol. Brain Res. 11, 161-166.
2. Battaglia, G., Norman, A. B., Newton, P. L. and Creese, I. (1985) In vitro and In vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2- dihydroquinoline (EEDQ): a technique for investigating S2 receptor recovery. J. Neurochem. 46, 589-592.
3. 1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethylcarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): evidence for spare receptors. Neurosci. Lett. 69, 290-295.
4. Belleau, B., Martel, R., Lacasse, G., Menard, M., Weinberg, N. L. and Perron, Y. G. (1969) N-Carboxylic esters of 1,2 and 1,4-dihydroquinolines. A new class of irreversible inactivators of the catecholamine alpha receptors and potent nervous system depressants. J. Am. Chem. Soc. 90, 823-824.
5. Berger, T. W., Kaul, S., Stricker, E. M. and Zigmond, M. J. (1985) Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats. Brain Res. 336, 354-358.
6. Breese, G. R., Baumeister, A. A., McCowan, T. J., Emerick, S. G., Frye, G. R., Crotty, K. and Mueller, R. A. (1984) Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromeswith reduced brain dopamine. J. Pharmacol. Exp. Ther. 231, 343-354.
7. 2-dopamine agonists into the nucleus accumbens and striatum without changing dopamine antagonist binding. J. Pharmacol. Exp. Ther. 240, 167-176.
8. Breese, G. R. and Traylor, T. D. (1971) Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine. Br. J. Pharmacol. 42, 88-99.
9. 2 receptors, adenylate cyclase activity and presynaptic dopamine function. Dev. Brain Res. 52, 273-277.
10. Burt, D. R., Creese, I. and Snyder, S. H. (1977) Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196, 326-328.
11. 2 receptor mRNA levels in the rat striatum: effects of unilateral intrastriatal injections of 6-hydroxydopamine. Mol. Brain Res. 12, 59-67.
12. Castaneda, E., Whishaw, I. Q., Lermer, L. and Robinson, T. E. (1990) Dopamine depletion in neonatal rats: effects on behavior and striatal dopamine release assessed by intracerebral microdialysis during adulthood. Brain Res. 508, 30-39.
13. 2 receptor mRNA levels caused by lesion of nigrostriatal pathway: a quantitative in situ hybridization study. Eur. J. Neurosci. 4, 663-672.
14. Crawford, C. A., McDougall, S. A., Rowlett, J. K. and Bardo, M. T. (1992) Depletion of dopamine binding sites and changes in dopamine and dihydroxyphenylacetic acid levels in 17- and 90-day-old rat striatum after irreversible receptor antagonism. Neurosci. Lett. 137, 265-269.
15. 2 dopamine receptors mRNAs: ontogenetic and pharmacological studies. Neurochem. Int. 20, 458-488.
16. 1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats. J. Neurosci. 9, 125-133.
17. 3H]Raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity. J. Pharmacol. Exp. Ther. 250, 696-706.
18. 1 receptors in adult rat neostriatum after neonatal 6-hydroxydopamine denervation. Brain Res. 536, 287-296.
19. 1 receptors during postnatal development. J. Neurochem. 61, 1255-1262.
20. 1 mRNA in the striatum of adult rats. Soc. Neurosci. Abst. 19, 1736.
21. 1 receptor development depends on endogenous dopamine. Dev. Brain Res. 56, 137-140.
22. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432.
23. 1dopamine receptors in the retina and in distinct areas of rat brain. J. Neurochem. 57, 754-759.
24. 1-dopamine receptors in the retina and in distinct areas of rat brain. Brain Res. 569, 323-329.
25. 1 receptor mRNA levels: absence of other neurochemical associations withthe enhanced behavioral responses of lesioned rats. J. Neurochem. 63, 1282-1290.
26. 1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2- dihydroquinoline in vivo and in vitro. Mol. Pharmacol. 31, 50-57.
27. 2 dopamine receptors. J. Neurosci. 8, 2361-2370.
28. 2 receptor contributions to ingestive and locomotor behavior are altered after dopamine depletions in neonatal rats. Neurosci. Lett. 118, 120-123.
29. Joyce, J. N. (1991) Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system. Exp. Neurol. 113, 261-276.
30. Kostrzewa, R. M. and Hamdi, A. (1991) Potentiation of spiperone-induced oral activity in rats after neonatal 6-hydroxydopamine. Pharmacol. Biochem. Behav. 38, 215-218.
31. 3H]raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in rat brain. Biochem. Pharmacol. 34, 2251-2259.
32. 2 dopamine receptor mRNA synthesis in a 6-hydroxydopamine parkinsonian rat model. Brain Res. Bull. 28, 697-701.
33. Lowry, O., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951) Protein measurements with Folin phenol reagent. J. biol. Chem. 193, 265-275.
34. Luthman, J., Bilioli, B., Tsutsumi, T., Verhofstad, A. and Jonsson, G. (1987) Sprouting of striatal serotonin nerve terminals following selective lesions of nigro-striatal dopamine neurons in neonatal rat. Brain Res. Bull. 19, 269-274.
35. Luthman, J., Lindqvist, E., Young, D. and Cowburn, R. (1990) Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity. Exp. Brain Res. 83, 85-95.
36. 2 receptor mRNA and opioid systems. Progr. clin. biol. Res. 328, 227-230.
37. Mauger, J. P., Sladeczek, F. and Bockaert, J. (1982) Characteristics and metabolism of α1 adrenergic receptors in a nonfusing muscle cell line. J. biol. Chem. 257, 875-879.
38. Molina-Holgado, E., Dewar, K. M., Descarries, L. and Reader, T. A. (1994) Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of ault rat after neonatal 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 270, 713-721.
39. Molina-Holgado, E., van Gelder, N. M., Dewar, K. M. and Reader, T. A. (1995) Dopamine receptor alterations correlate with increased GABA levels in adult rat neostriatum: effects of a neonatal 6-hydroxydopamine denervation. Neurochem. Int. 27, 443-451.
40. 1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development. Dev. Brain Res. 60, 105-113.
41. 2 receptors. Synapse 11, 35-46.
42. 2 receptors after irreversible receptor blockade. Brain Res. 329, 225-231.
43. 2 dopamine receptor mRNA after denervation. Proc. natn. Acad. Sci. USA 88, 2802-2806.
44. Nicklaus, K. J., McGonigle, P. and Molinoff, P. B. (1988) [3H]SCH23390 labels both dopamine-1 and 5-hydroxy tryptamine 1C receptors in the choroid plexus. J. Pharmacol. Exp. Ther. 247, 343-347.
45. 2-dopamine receptor reappearance after irreversible receptor blockade. Brain Res. 435, 147-152.
46. Potter, B. M. and Bruno, J. P. (1989) Food intake of rats depleted of dopamine as neonates is impaired by inhibition of catecholamine biosynthesis. Neurosci. Lett. 107, 295-300.
47. 2 dopamine receptors. J. Neurochem. 62, 411-420.
48. 2 receptors in adult rat neostriatum after neonatal dopamine denervation: quantitative data from ligand binding, in situ hybridization and iontophoresis. Neuroscience 57, 635-648.
49. Reader, T. A. and Grondin, L. (1987) Distribution of catecholamines, serotonin, and their major metabolites in rat cingulate, piriform-entorhinal, somatosensory and visual cortex: a biochemical survey using high-performance liquid chromatography. Neurochem. Res. 12, 1087-1097.
50. 1 receptors in cerebral cortex and neostriatum: evidences for heterogeneities in affinity states and cortical distribution. J. Neurochem. 50, 451-465.
51. Reader, T. A., Radja, F., Dewar, K. M. and Descarries, L. (1995) Denervation, hyperinnervation and interactive regulation of dopamine and serotonin receptors. Ann. NY Acad. Sci. 757, 293-310.
52. 2 dopamine receptors during aging. Brain Res. 575, 309-314.
53. 2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study. Neuroscience 46, 729-738.
54. 2 receptor mRNA in rat brain. J. Mol. Neurosci. 2, 155-161.
55. Stachowiak, M. K., Bruno, J. P., Snyder, A. M., Stricker, E. M. and Zigmond, M. J. (1984) Apparent sprouting of striatal serotoninergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res. 291, 164-167.
56. 2 dopamine receptor mRNA levels. Neurosci. Lett. 111, 303-308.